Volume 34, Issue 7 , Pages 401-407, September 2006
Risk factors for nosocomial urinary tract–related bacteremia: A case-control study
Background
Risk factors for bacteremia in patients with hospital-acquired bacteriuria are largely unknown. Given the morbidity and costs associated with nosocomial bacteremia, determining risk factors could enhance the safety of hospitalized patients.
Methods
We conducted a case-control study within the Veterans Affairs Puget Sound Health Care System. A patient hospitalized between 1984 and 1999 from whom a urine culture and a blood culture grew the same organism ≥48 hours after admission was considered a case. Control patients were those with significant bacteriuria detected ≥48 hours after admission who did not have a positive blood culture. We used logistic regression to determine independent risk factors for bacteremia.
Results
There were 95 cases and 142 controls. Independent, statistically significant predictors of bacteremia included immunosuppressant therapy within 14 days of bacteriuria (odds ratio [OR], 8.13); history of malignancy (OR, 1.94); male sex (OR, 1.88); cigarette use in the past 5 years (OR, 1.26); number of hospital days before bacteriuria (OR, 1.03); and antibiotic use within 3 days of bacteriuria (OR, 0.76). Corticosteroid use within 7 days of bacteriuria predicted bacteremia in patients <70 years old (OR, 14.24). Similarly, patients <70 years old were more likely to develop bacteremia if they had diabetes mellitus (OR, 6.19).
Conclusion
Delineating risk factors for nosocomial urinary tract-related bacteremia can help target appropriate preventive practices at the highest risk patients.
To access this article, please choose from the options below
Supported by a Department of Veterans Affairs Epidemiologic Research and Information Center research grant (EPP-97-015; to B.A.L. and S.S.), a Career Development Award from the Health Services Research and Development Program of the Department of Veterans Affairs (to S.S.), and a Patient Safety Developmental Center Grant from the Agency for Healthcare Research and Quality (P20-HS11540; to S.S.).Preliminary results of this study were presented at the 41st Annual Meeting of the Infectious Diseases Society of America in San Diego, CA, on October 11, 2003, and the 27th Annual Meeting of the Society of General Internal Medicine in Chicago, IL, on May 13, 2004.
PII: S0196-6553(06)00138-6
doi:10.1016/j.ajic.2006.03.001
© 2006 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc All rights reserved.
Volume 34, Issue 7 , Pages 401-407, September 2006
